Performance analysis of Gracell Biotechnologies (GRCL)
Annual Return
Over the past 3 years, GRCL has had an average annual return of +49.73%, outperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, GRCL has had an average annual return of -5.14%, underperforming the benchmark SPY, which returned +14.05% annual.
Since Jan 8, 2021, GRCL has had an average annual return of -15.26%, underperforming the benchmark SPY, which returned +15.14% annual.
| 2026 | 2024 | 2023 | 2022 | 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | +2.10% | +336.38% | -61.91% | -75.90% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | +0% | |||||||
| 2024 | +1.80% | +0.29% | +2.10% | ||||||||||
| 2023 | -6.54% | -6.53% | -7.48% | -6.47% | +57.49% | +39.07% | -1.05% | -12.97% | -12.22% | +16.71% | +44.89% | +106.18% | +336.38% |
| 2022 | -41.20% | -10.16% | -26.94% | -3.44% | +46.21% | +67.17% | -35.81% | -28.89% | +28.24% | -0.93% | +1.89% | -29.22% | -61.91% |
| 2021 | -17.32% | +9.70% | -32.25% | -20.91% | +23.66% | -13.68% | -4.39% | -16.09% | +32.99% | -22.85% | -27.66% | -21.98% | -75.90% |
Drawdown analysis of Gracell Biotechnologies (GRCL)
The maximum drawdown for the GRCL was -95.25%, occurring on Apr 25, 2023. This drawdown has not yet recovered.
The current GRCL drawdown is -66.47%.
Since Jan 8, 2021 GRCL has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.25% | Feb 5, 2021 | 557 | Apr 25, 2023 | Ongoing | Ongoing | Ongoing |
| -19.83% | Jan 12, 2021 | 11 | Jan 28, 2021 | 3 | Feb 2, 2021 | 14 |
| -3.05% | Feb 3, 2021 | 1 | Feb 4, 2021 | 1 | Feb 5, 2021 | 2 |
| -1.04% | Jan 8, 2021 | 1 | Jan 11, 2021 | 1 | Jan 12, 2021 | 2 |